Trials / Completed
CompletedNCT03214081
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
Special Drug Use Surveillance of Takecab Tablets for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,237 (actual)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this survey is to evaluate the safety and effectiveness of long-term administration of vonoprazan tablets when used as maintenance therapy for reflux esophagitis in routine clinical settings.
Detailed description
The drug being tested in this survey is called vonoprazan. Vonoprazan is being tested to treat patients who have reflux esophagitis. This survey will look at the safety and effectiveness of long-term administration of vonoprazan tablets when used as maintenance therapy for reflux esophagitis in routine clinical settings. The survey will enroll approximately 1000 participants. \- Vonoprazan 10 mg or 20 mg This multi-center observational trial will be conducted in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vonoprazan | Vonoprazan tablets |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
- First posted
- 2017-07-11
- Last updated
- 2025-06-10
- Results posted
- 2019-10-23
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03214081. Inclusion in this directory is not an endorsement.